75 Participants Needed

tDCS for Cognitive Improvement in Healthy Subjects

MG
MC
Overseen ByMinhtrang Chu
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Davis
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique, affects thinking and memory skills in healthy individuals. It aims to understand the roles of different brain regions, such as the frontal and occipital areas, in tasks involving language, attention, and memory. Participants are divided into groups: some receive actual brain stimulation, while others undergo a placebo (fake) treatment. Suitable candidates have no history of head trauma and do not take psychiatric medications. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research on brain function and cognitive enhancement.

Do I need to stop my current medications for the trial?

The trial does not specify if you need to stop taking your current medications, but it excludes those with a history of treatment with psychotropic medication (drugs affecting mood, perception, or behavior).

What prior data suggests that transcranial direct current stimulation (tDCS) is safe for cognitive improvement studies?

Research has shown that transcranial direct current stimulation (tDCS) is generally safe and well-tolerated. Studies focusing on the dorsolateral prefrontal cortex (DLPFC) have found tDCS to be safe, with no serious side effects reported. This indicates it could be a promising method for treating various conditions without major safety concerns.

For stimulation of the occipital cortex, past research also supports its safety. The tDCS methods used in this trial mirror those in previous studies, which have not resulted in serious adverse effects. Some minor effects, like skin irritation, might occur but are not considered serious.

Overall, evidence suggests that tDCS, when used as described in similar studies, is safe for participants.12345

Why are researchers excited about this trial?

Researchers are excited about transcranial direct current stimulation (tDCS) because it offers a non-invasive way to potentially boost cognitive function by using low-level electrical currents. Unlike traditional cognitive enhancers that rely on medication, tDCS directly targets brain areas like the dorsolateral prefrontal cortex and the occipital cortex to modulate neural activity. This approach could offer a safer alternative with fewer side effects compared to drugs, and it might provide quicker results. By exploring different stimulation sites, like the DLPFC and occipital cortex, researchers hope to better understand and maximize the cognitive benefits of tDCS.

What evidence suggests that transcranial direct current stimulation (tDCS) is effective for cognitive improvement?

Research has shown that transcranial direct current stimulation (tDCS) can improve thinking skills. In this trial, participants may receive stimulation targeting the dorsolateral prefrontal cortex (DLPFC), which previous studies have shown can significantly enhance cognitive abilities, especially with higher electrical currents. One study revealed that 68.6% of participants who received active tDCS reported better cognitive performance, compared to 31.4% in the group that received a sham treatment.

This trial also includes an arm where participants receive stimulation at the back of the brain, specifically the occipital cortex. Research suggests that tDCS in this area can boost overall thinking abilities, as seen in conditions like mild cognitive impairment and Alzheimer's disease. It may also aid in cognitive training for conditions like schizophrenia. Overall, tDCS shows promise in improving brain functions related to thinking and memory.678910

Are You a Good Fit for This Trial?

This trial is for healthy individuals aged 18-50 who speak and understand English well enough to complete cognitive tasks. They must be able to consent to the study. People with head trauma, psychotropic medication use, poor vision without correction, or conditions that contraindicate tDCS/MRI (like pregnancy or metal in the body) cannot participate.

Inclusion Criteria

I understand the study and can agree to participate.
I understand the study and can agree to participate.
ability to sufficiently speak and understand English so as to be able to understand and complete cognitive tasks
See 1 more

Exclusion Criteria

I have never had a head injury.
I am not pregnant, have no metal in my body, no serious health issues, no claustrophobia, no metallic implants, no skin conditions at electrode sites, and no brain disorders.
Corrected vision 20/30 or better
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex or occipital cortex, or sham stimulation

1 month
Multiple sessions, each lasting 20 minutes

Follow-up

Participants are monitored for cognitive performance using behavioral and electrophysiological measures

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Transcranial Direct Current Stimulation
Trial Overview The study tests how transcranial direct current stimulation (tDCS) affects higher-order cognition like language comprehension and memory in healthy people and those with schizophrenia. It compares effects of stimulating different brain regions using behavioral tasks and EEG monitoring.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Occipital StimulationExperimental Treatment1 Intervention
Group II: DLPFC StimulationExperimental Treatment1 Intervention
Group III: Sham StimulationPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Davis

Lead Sponsor

Trials
958
Recruited
4,816,000+

Published Research Related to This Trial

A systematic review of 64 studies involving 2262 participants found that transcranial direct current stimulation (tDCS) has a low dropout rate (6% for active and 7.2% for sham), indicating good acceptability among participants.
Despite the low dropout rates, many studies inadequately reported adverse events (AEs), highlighting a need for improved guidelines to standardize AE reporting in tDCS research.
A Systematic Review on the Acceptability and Tolerability of Transcranial Direct Current Stimulation Treatment in Neuropsychiatry Trials.Aparรญcio, LVM., Guarienti, F., Razza, LB., et al.[2018]
Transcranial direct current stimulation (tDCS) has a small but significant effect on improving reaction times in cognitive tasks for healthy older adults, particularly when applied online during tasks related to learning and memory, as well as executive function.
In contrast, offline tDCS did not show any significant impact on reaction times, indicating that the timing and method of tDCS application are crucial for its efficacy in enhancing cognitive functions in the elderly.
Transcranial direct current stimulation decreased cognition-related reaction time in older adults: A systematic review and meta-analysis.Lee, JH., Lee, TL., Kang, N.[2021]
Anodal transcranial direct current stimulation (tDCS) significantly improved cognitive performance in healthy elderly individuals by increasing neural activity, as evidenced by enhanced P200 and P300 amplitudes during a working memory task.
Cathodal tDCS also showed potential benefits for Alzheimer's disease patients, increasing P200 amplitude and frontal theta activity, suggesting that tDCS can modulate neural function differently based on the individual's cognitive state.
Behavioural and electrophysiological modulations induced by transcranial direct current stimulation in healthy elderly and Alzheimer's disease patients: A pilot study.Cespรณn, J., Rodella, C., Miniussi, C., et al.[2020]

Citations

Efficacy of transcranial direct current stimulation on ...tDCS demonstrated substantial efficacy in enhancing overall cognition in patients with PD. The efficacy of tDCS was obvious in executive function, language, ...
Transcranial direct current stimulation (tDCS) enhances ...A higher proportion of patients in active tDCS (68.6%) reported cognitive improvement compared to sham tDCS (31.4%). We concluded that tDCS can enhance ...
Effect of transcranial direct current stimulation with ...Our results suggest that tDCS targeting the PPC relative to the DLPFC during concurrent cognitive performance may improve working memory in schizophrenia.
Transcranial Direct Current Stimulation Enhances Cognitive ...Another meta-analysis found that anodic stimulation of tDCS on DLPFC significantly improved cognitive ability, especially at high-current ...
A systematic review and meta-analysis of the impact of ...tDCS demonstrated efficacy in enhancing global cognition in older people with cognitive impairments, providing insight into optimal parameters for clinical ...
Feasibility and Safety of Sequential Transcranial ...This study provides preliminary evidence about the feasibility, safety, and challenges to combine PT and tDCS in very frail older adults.
Effects of Transcranial Direct Current Stimulation Targeting ...In conclusion, the tDCS targeting DLPFC may be a potentially effective therapeutic target for alleviating somatic symptoms in patients with MDD.
Prefrontal Transcranial Direct Current Stimulation in ...... tDCS over the prefrontal cortex . . . was safe and well tolerated", as well as the conclusion that "To establish tCDS as a therapeutic ...
Frontal two-electrode transcranial direct current stimulation ...The present study suggests that single-session tDCS delivered in two two-electrode montages might not affect cognitive control or response inhibition.
Transcranial direct current stimulation to the left ...This study aimed to investigate whether tDCS over the left DLPFC improves non-dominant hand dexterity performance and determine if its efficacy depends on the ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity